Ligand validation:6ZDR

OLA: OLEIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZDR_OLA_A_1210	27%	86%	0.177	0.858	0.27	0.45	-	-	0	0	80%	0.8
6ZDR_OLA_A_1220	21%	83%	0.2	0.905	0.2	0.57	-	-	1	0	45%	0.45
6ZDR_OLA_A_1214	17%	68%	0.226	0.881	0.27	0.96	-	-	1	0	60%	0.6
6ZDR_OLA_A_1207	15%	87%	0.194	0.888	0.26	0.43	-	-	0	0	25%	0.25
6ZDR_OLA_A_1206	14%	84%	0.18	0.774	0.25	0.51	-	-	0	0	75%	0.75
6ZDR_OLA_A_1209	14%	86%	0.171	0.826	0.24	0.48	-	-	0	0	40%	0.4
6ZDR_OLA_A_1215	6%	79%	0.255	0.678	0.28	0.57	-	-	1	0	100%	1
6ZDR_OLA_A_1218	5%	82%	0.216	0.662	0.27	0.52	-	-	0	0	75%	0.75
6ZDR_OLA_A_1208	4%	80%	0.206	0.641	0.33	0.5	-	-	0	0	70%	0.7
6ZDR_OLA_A_1219	3%	79%	0.194	0.626	0.26	0.6	-	-	0	0	55%	0.55
6ZDR_OLA_A_1217	1%	80%	0.286	0.567	0.24	0.59	-	-	0	0	55%	0.55
5IUA_OLA_A_2406	50%	87%	0.151	0.9	0.42	0.27	-	-	0	0	100%	1
5OLV_OLA_A_1227	48%	62%	0.127	0.869	0.68	0.79	-	2	1	0	100%	0.67
5MZJ_OLA_A_2405	47%	88%	0.14	0.877	0.39	0.27	-	-	3	0	100%	1
5IU7_OLA_A_2406	45%	88%	0.146	0.876	0.43	0.25	-	-	1	0	100%	1
5OLZ_OLA_A_1206	43%	64%	0.151	0.875	0.66	0.71	-	1	0	0	100%	1
6DJ6_OLA_B_402	92%	68%	0.081	0.971	0.55	0.69	-	-	0	0	100%	1
1LFO_OLA_A_128	79%	59%	0.097	0.943	0.78	0.79	1	-	0	0	100%	1
8GEW_OLA_A_202	64%	57%	0.138	0.938	0.69	0.94	-	2	0	0	100%	0.44
7V3K_OLA_D_401	55%	65%	0.16	0.928	0.6	0.74	-	-	2	0	100%	1
7KAZ_OLA_B_600	54%	53%	0.126	0.891	0.82	0.99	1	1	0	0	100%	0.87

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.